Keyphrases
Coronavirus Disease (COVID)
100%
COVID-19
91%
Patients with COVID-19
80%
Critically Ill Patients
75%
Septic Shock
73%
Days Alive without Life Support
72%
Low-dose Hydrocortisone
66%
On Demand
66%
Blood Samples
66%
Severe Hypoxia
66%
Statistical Analysis Plan
66%
Number of Days
55%
Intravenous Fluids
50%
Corticosteroids
50%
Intensive Care Unit
47%
Mechanical Ventilation
40%
Randomized Trial
38%
Intensive Care Unit Patients
38%
Serious Adverse Reaction
35%
Scoping Review
33%
Liberal Fluid Therapy
33%
Severe Hypoxemia
33%
Trial Protocol
33%
Randomized Placebo-controlled Trial
33%
Hydrocortisone
33%
Protocol Analysis
33%
Routine Blood Testing
26%
Blood Test
26%
Certainty of Evidence
26%
Placebo
25%
Restrictive Fluid
22%
Adjusted Relative Risk
20%
Adult Patients
19%
Confidence Interval
19%
Daily Routines
17%
Intravenous Fluid Therapy
16%
Fluid Restriction
16%
Clinical Trials
16%
Adjusted Means
15%
Support Replacement
15%
Circulatory Support
15%
Interim Analysis
13%
Health-related Quality of Life
13%
Intention-to-treat
13%
Statistical Analysis
13%
Clinical Equipoise
13%
Intravenous Dexamethasone
13%
Transfusion Rate
13%
Transfusion Burden
13%
Routine Blood
13%
Medicine and Dentistry
Hypoxia
66%
Hydrocortisone
66%
Septic Shock
66%
COVID-19
66%
Low Drug Dose
66%
Intensive Care Unit
57%
Infusion Fluid
50%
Placebo
40%
Blood Sampling
33%
Fluid Therapy
33%
Adverse Event
28%
Artificial Respiration
25%
Clinical Trial
17%
Intravenous Drug Administration
16%
Meta-Analysis
13%
Intensive Care
12%
Interim Analysis
12%
Intention-to-Treat Analysis
12%
Clinical Equipoise
12%
Quality of Life
12%
Viral Clearance
6%
All Cause Mortality
6%
Coronavirinae
6%
Respiratory Failure
6%
Assisted Circulation
6%
Disease
6%
Patient Population
6%
Sodium Chloride
6%
Renal Replacement Therapy
6%
Severe Acute Respiratory Syndrome Coronavirus 2
6%
Cognition
5%
Clinician
5%
Shock (Circulatory)
5%
Logistic Regression Analysis
5%
Pharmacology, Toxicology and Pharmaceutical Science
Hypoxia
66%
Hydrocortisone
66%
Adverse Event
64%
Placebo
50%
Septic Shock
35%
Hypoxemia
33%
Dexamethasone
33%
Infusion Fluid
33%
Observational Study
33%
Dextromethorphan
33%
Clinical Trial
30%
Disease
18%
Replacement Therapy
18%
All Cause Mortality
16%
SARS Coronavirus
16%
Coronavirinae
16%
Sodium Chloride
16%
Respiratory Failure
16%
Viral Clearance
16%
